Comparison of clinical characteristics between patients with ALK-positive and EGFR-positive lung adenocarcinoma

Respiratory Medicine

Volumn 108, Issue 2, 2014, Pages 388-394

  Kang, Hyo Jae ^a,c   Lim, Hyo Jeong ^a,b   Park, Jong Sun ^a,b   Cho, Young Jae ^a,b   Yoon, Ho Il ^a,b   Chung, Jin Haeng ^a   Lee, Jae Ho ^a,b   Lee, Choon Taek ^a,b  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c National Cancer Center   (South Korea)

Author keywords

Bronchoscopy; EGFR; EML4 ALK; Lung adenocarcinoma

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; ECHINODERM MICROTUBULE ASSOCIATED PROTEIN LIKE 4 LYMPHOMA KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR; HYBRID PROTEIN; UNCLASSIFIED DRUG;

ADRENAL METASTASIS; ADULT; AGED; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; BRONCHOSCOPY; CANCER SCREENING; CANCER STAGING; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY METASTASIS; LIVER METASTASIS; LUNG ADENOCARCINOMA; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PANCREAS METASTASIS; PLEURA METASTASIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; VERY ELDERLY;

BRONCHOSCOPY; EGFR; EML4-ALK; LUNG ADENOCARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BRONCHOSCOPY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; NEOPLASM STAGING; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETROSPECTIVE STUDIES;

EID: 84893762065     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2013.11.020     Document Type: Article

References (24)

1. M.J. Thun, J.O. DeLancey, M.M. Center, A. Jemal, and E.M. Ward The global burden of cancer: priorities for prevention Carcinogenesis 31 2010 100 110
2. J.H. Schiller, D. Harrington, C.P. Belani, C. Langer, A. Sandler, and J. Krook et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer N Engl J Med 346 2002 92 98
3. T.S. Mok, Y.L. Wu, S. Thongprasert, C.H. Yang, D.T. Chu, and N. Saijo et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma N Engl J Med 361 2009 947 957
4. M. Soda, Y.L. Choi, M. Enomoto, S. Takada, Y. Yamashita, and S. Ishikawa et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer Nature 448 2007 561 566
5. J.P. Koivunen, C. Mermel, K. Zejnullahu, C. Murphy, E. Lifshits, and A.J. Holmes et al. EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer Clin Cancer Res 14 2008 4275 4283
6. R. Chiarle, C. Voena, C. Ambrogio, R. Piva, and G. Inghirami The anaplastic lymphoma kinase in the pathogenesis of cancer Nat Rev Cancer 8 2008 11 23
7. E.L. Kwak, Y.J. Bang, D.R. Camidge, A.T. Shaw, B. Solomon, and R.G. Maki et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer N Engl J Med 363 2010 1693 1703
8. D.R. Camidge, Y.J. Bang, E.L. Kwak, A.J. Iafrate, M. Varella-Garcia, and S.B. Fox et al. Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study Lancet Oncol 13 2012 1011 1019
9. Y. Koh, D.W. Kim, T.M. Kim, S.H. Lee, Y.K. Jeon, and D.H. Chung et al. Clinicopathologic characteristics and outcomes of patients with anaplastic lymphoma kinase-positive advanced pulmonary adenocarcinoma: suggestion for an effective screening strategy for these tumors J Thorac Oncol 6 2011 905 912
10. S.J. Rodig, M. Mino-Kenudson, S. Dacic, B.Y. Yeap, A. Shaw, and J.A. Barletta et al. Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population Clin Cancer Res 15 2009 5216 5223
11. A.T. Shaw, B.Y. Yeap, M. Mino-Kenudson, S.R. Digumarthy, D.B. Costa, and R.S. Heist et al. Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK J Clin Oncol 27 2009 Sep 4247 4253
12. K. Inamura, K. Takeuchi, Y. Togashi, S. Hatano, H. Ninomiya, and N. Motoi et al. EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset Mod Pathol 22 2009 508 515
13. D.W. Wong, E.L. Leung, K.K. So, I.Y. Tam, A.D. Sihoe, and L.C. Cheng et al. The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS Cancer 115 2009 1723 1733
14. T. Takahashi, M. Sonobe, M. Kobayashi, A. Yoshizawa, T. Menju, and E. Nakayama et al. Clinicopathologic features of non-small-cell lung cancer with EML4-ALK fusion gene Ann Surg Oncol 17 2010 889 897
15. J.H. Paik, G. Choe, H. Kim, J.Y. Choe, H.J. Lee, and C.T. Lee et al. Screening of anaplastic lymphoma kinase rearrangement by immunohistochemistry in non-small cell lung cancer: correlation with fluorescence in situ hybridization J Thorac Oncol 6 2011 466 472
16. F.C. Detterbeck, D.J. Boffa, and L.T. Tanoue The new lung cancer staging system Chest 136 2009 260 271
17. J.H. Paik, C.M. Choi, H. Kim, S.J. Jang, G. Choe, and D.K. Kim et al. Clinicopathologic implication of ALK rearrangement in surgically resected lung cancer: a proposal of diagnostic algorithm for ALK-rearranged adenocarcinoma Lung Cancer 76 2012 403 409
18. J.H. Chung, G. Choe, S. Jheon, S.W. Sung, T.J. Kim, and K.W. Lee et al. Epidermal growth factor receptor mutation and pathologic-radiologic correlation between multiple lung nodules with ground-glass opacity differentiates multicentric origin from intrapulmonary spread J Thorac Oncol 4 2009 1490 1495
19. T. Sasaki, S.J. Rodig, L.R. Chirieac, and P.A. Janne The biology and treatment of EML4-ALK non-small cell lung cancer Eur J Cancer 46 2010 1773 1780
20. N.I. Lindeman, P.T. Cagle, M.B. Beasley, D.A. Chitale, S. Dacic, and G. Giaccone et al. Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology J Thorac Oncol 8 2013 823 859
21. P. Yang, K. Kulig, J.M. Boland, M.R. Erickson-Johnson, A.M. Oliveira, and J. Wampfler et al. Worse disease-free survival in never-smokers with ALK+ lung adenocarcinoma J Thorac Oncol 7 2012 90 97
22. T. Fukui, Y. Yatabe, Y. Kobayashi, K. Tomizawa, S. Ito, and S. Hatooka et al. Clinicoradiologic characteristics of patients with lung adenocarcinoma harboring EML4-ALK fusion oncogene Lung Cancer 77 2012 319 325
23. O. Campobasso The characteristics of peripheral lung tumours that suggest their bronchiolo-alveolar origin Br J Cancer 22 1968 655 662
24. M.J. Matthews Morphology of lung cancer Semin Oncol 1 1974 175 182